Nasdaq-listed Canton Strategic Holdings has completed the sale of its biotech research and development unit, Gravitas Life Sciences, according to PRNewswire. The buyer was Gravitas Collective Corp, and the transaction received unanimous approval from the company’s board of directors. Canton Strategic said the deal was formally completed on July 17, 2026. The company said the divestiture reflects its continued shift toward becoming an operating business focused on advancing the digitization of traditional financial markets through Canton Network. Its stated priorities include asset tokenization, the broader digitization of financial markets, and financial infrastructure operations. The announcement ties the completed sale directly to the company’s strategic repositioning away from its biotech R&D business and toward digital financial market infrastructure.
Nasdaq-listed Canton Strategic Holdings has completed the sale of its biotech research and development division, Gravitas Life Sciences, according to PRNewswire. The buyer was Gravitas Collective Corp.
The company said the transaction was unanimously approved by its board of directors and was formally completed on July 17, 2026.
Canton Strategic said the sale marks its continued transition into an operating company centered on Canton Network and focused on the digitization of traditional financial markets. The company said its priorities include asset tokenization, the digitization of financial markets, and financial infrastructure business lines.
This article was originally published by Bit.Fan. For more cryptocurrency news and market insights, visit www.bit.fan. Disclaimer:
The market information, project data, and third-party content displayed on this platform are for industry information sharing only and do not constitute any form of investment advice or return commitment.
Cryptocurrency trading carries high risks. Users should fully assess their risk tolerance and make independent decisions. All profits, losses, and legal responsibilities are borne by the users themselves.
